Skip to main content
Log in

Genotoxic effects of N-nitrosoketamine and ketamine as assessed by in vitro micronucleus test in Chinese hamster lung fibroblast cell line

  • Original Article
  • Published:
Environmental Health and Preventive Medicine Aims and scope

Abstract

Objectives

Ketamine hydrochloride (KT) is a secondary amine that has been safely used as an injectable anesthetic and analgesic to avoid the production of nitroso compounds in the stomach. However, ketamine in the tablet form has recently become an abused, recreational drug. The aim of this study was to investigate the genotoxic effects of N-nitrosoketamine (NKT) and KT on the basis of an in vitro micronucleus (MN) test using a Chinese hamster lung fibroblast cell line (CHL/IU).

Methods

NKT was synthesized from KT in our laboratory. In the MN tests, CHL/IU cells were continuously treated with either NKT or KT for 24, 48, or 72 hours without the S9 mix. The cells were also treated with NKT or KT with or without the S9 mix for 6 hours, followed by a recovery period of 18, 42, or 66 hours (short-term treatment). The results were considered to be statistically significant when the p-values of both Fisher’s exact test and the trend test were less than 0.05.

Results

After the short-term treatment with either NKT or KT with and without the S9 mix, the frequency of micronuclei significantly increased. However, the frequency of micronuclei did not significantly increase after the continuous treatment with either NKT or KT. Both NKT and KT were determined to be genotoxic in the short-term treatment with or without the S9 mix, but they were determined to be nongenotoxic in continuous treatment.

Conclusion

Our findings suggest that NKT has a stronger genotoxic effect than KT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lijinsky W. Reaction of drugs with nitrous acid as a source of carcinogenic nitrosamines. Cancer Res. 1974;34:255–258.

    PubMed  CAS  Google Scholar 

  2. Raineri R, Poiley JA, Andrews AW, Pienta RJ, Lijinsky W. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella. J Natl Cancer Inst. 1981;67:1117–1122.

    PubMed  CAS  Google Scholar 

  3. Sen NP, Smith DC, Schwinghamer L. Formation of N-nitrosamines from secondary amines and nitrite in human and animal gastric juice. Food Cosmet Toxicol. 1969;7:301–307.

    Article  PubMed  CAS  Google Scholar 

  4. Cardesa A, Pour P, Althoff J, Mohr U. Vascular tumors in female mice after intraperitoneal injection of dimethylnitrosamine. J Natl Cancer Inst. 1973;51:201–208.

    PubMed  CAS  Google Scholar 

  5. Druckrey H, Preussmann R, Ivankovic S, Schmahl D. Organotropic carcinogenic effects of 65 various N-nitrosocompounds on BD rats. Z Krebsforsch. 1967;69:103–201.

    Article  PubMed  CAS  Google Scholar 

  6. Magee PN, Barnes JM. The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine. Br J Cancer. 1956;10:114–122.

    PubMed  CAS  Google Scholar 

  7. Toth B, Magee PN, Shubik P. Carcinogenesis study with dimethyl-nitrosamine administered orally to adult and subcutaneously to newborn BALB/C mice. Cancer Res. 1964; 64:1712–1721.

    Google Scholar 

  8. Dalgarno PJ, Shewan D. Illicit use of ketamine in Scotland. J Psychoactive Drugs. 1996;28:191–199.

    PubMed  CAS  Google Scholar 

  9. Siegel RK. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. NIDA Res Monogr. 1978;21:119–147.

    PubMed  Google Scholar 

  10. Jansen KL. Ketamine—can chronic use impair memory? Int J Addict. 1990;25:133–139.

    PubMed  CAS  Google Scholar 

  11. Kammaya H, Krishna PR. Ketamine addiction. Anesthesiology. 1987;67:861–862.

    Article  Google Scholar 

  12. Hurt PH, Ritchie EC. A case of ketamine dependence. Am J Psychiatry. 1994;151:779.

    PubMed  CAS  Google Scholar 

  13. Heddle JA, Hite M, Kirkhart B, Mavournin K, MacGregor JT, Newell GW, Salamone MF. The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res. 1983;123:61–118.

    PubMed  CAS  Google Scholar 

  14. Matsushima T, Hayashi M, Matsuoka A, Ishidate M Jr, Miura KF, Shimizu H, Suzuki Y, Morimoto K, Ogura H, Mure K, Koshi K, Sohuni T. Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis. 1999;14:569–580.

    Article  PubMed  CAS  Google Scholar 

  15. Li J, Suzuki Y, Shimizu H, Fukumoto M, Okonogi H, Nagashima T, Ishikawa T. In vitro micronucleus assay of 30 chemicals in CHL cells. Jikeikai Med J. 1993;40:69–83.

    CAS  Google Scholar 

  16. Cochran WG. Some methods for strengthening the common 2 tests. Biometrics. 1954;10:417–451.

    Article  Google Scholar 

  17. Armitage P. Test for linear trends in proportions and frequencies. Biometries. 1955;11:375–386.

    Article  Google Scholar 

  18. Scott D, Galloway SM, Marshall RR, Ishidate M Jr, Brusick D, Ashby J, Myhr BC. International commission for protection against environmental mutagens and carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Mutat Res. 1991;257:147–205.

    PubMed  CAS  Google Scholar 

  19. Morel G, Ban M, Bonnet P, Zissu D, Brondeau MT. Effect of beta-naphthoflavone and phenobarbital on the nephrotoxicity of chlorotrifluoroethylene and 1,1-dichloro-2,2-difluoroethylene in the rat. J Appl Toxicol. 2005;25:153–165.

    Article  PubMed  CAS  Google Scholar 

  20. Garcia Franco S, Dominguez G, Pico JC. Alternatives in the induction and preparation of phenobarbital/naphthoflavoneinduced S9 and their activation profiles. Mutagenesis. 1999; 14:323–326.

    Article  PubMed  CAS  Google Scholar 

  21. Adhvaryu SG, Trivedi AH, Jani KH, Vyas RC, Dave BJ. Genotoxic effects of ketamine on CHO cells. Arch Toxicol. 1986;59:124–125.

    Article  PubMed  CAS  Google Scholar 

  22. Yanagihara Y, Kariya S, Ohtani M, Uchino K, Aoyama T, Yamamura Y, Iga T. Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos. 2001; 29:887–890.

    PubMed  CAS  Google Scholar 

  23. Shimizu H, Takemura N, Ando H, Morita M, Machida K. Mutagenic activity of N-nitrosomethamphetamine and N-nitrosoephedrine. Cancer Lett. 1983;21:63–68.

    Article  PubMed  CAS  Google Scholar 

  24. Newbold RF, Warren W, Medcalf AS, Amos J. Mutagenicity of carcinogenic methylating agents is associated with a specific DNA modification. Nature. 1980;283:596–599.

    Article  PubMed  CAS  Google Scholar 

  25. Yanagihara Y, Ohtani M, Matsumoto M, Kariya S, Uchino K, Hiraishi T, Ashizawa N, Aoyama T, Yamamura Y, Iga T. Preparation of ketamine tablets for treatment of patients with neuropathic pain. Yakugaku Zasshi. 1999;119:980–987. (Article in Japanese)

    PubMed  CAS  Google Scholar 

  26. Weiner AL, Vieira L, McKay CA, Bayer MJ. Ketamine abusers presenting to the emergency department: a case series. J Emerg Med. 2000;18:447–451.

    Article  PubMed  CAS  Google Scholar 

  27. Felser JM, Orban DJ. Dystonic reaction after ketamine abuse. Ann Emerg Med. 1982;11:673–675.

    Article  PubMed  CAS  Google Scholar 

  28. Dillman J. Ketamine abuse—a new edge. Todays Surg Nurse. 1998;20:37–39.

    Google Scholar 

  29. Jansen KL. Non-medical use of ketamine. BMJ. 1993;306:601–602.

    Article  PubMed  CAS  Google Scholar 

  30. Shewan D, Dalgarno P. Ecstasy and neurodegeneration. …such as ketamine. BMJ. 1996;313:424.

    PubMed  CAS  Google Scholar 

  31. Katagi M, Tsutsumi H, Miki A, Nakajima K, Tsuchihashi H. Analyses of clandestine tablets of amphetamines and their related designer drugs encountered in recent Japan. Japanese Journal of Forensic Toxicology. 2002;20:303–319.

    CAS  Google Scholar 

  32. Makino Y, Tanaka S, Kurobane S, Nakauchi M, Terasaki T, Ohta S. Profiling of illegal amphetamine-type stimulant tablets in Japan. J Health Sci. 2003;49:129–137.

    Article  Google Scholar 

  33. Kawaguchi T, Harada M, Arimatsu H, Nagata S, Koga Y, Kuwahara R, Hisamochi A, Hino T, Taniguchi E, Kumemura H, Hanada S, Maeyama M, Koga H, Tomiyasu N, Toyomasu H, Kawaguchi M, Kage M, Kumashiro R, Tanikawa K, Sata M. Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases. J Gastroenterol Hepatol. 2004:19:349–350.

    Article  PubMed  Google Scholar 

  34. Ando H, Morita M. Possibility of in vitro and in vivo formations of N-nitrosomethamphetamine. Reports of National Research Institute of Police Science. 1983;36:16–20. (Article in Japanese)

    CAS  Google Scholar 

  35. Shimizu H, Takemura N, Ando H, Morita M, Machida K. The in vivo formation of mutagenic N-nitroso compounds from methamphetamine and ephedrine. Nippon Eiseigaku Zasshi. 1984;39:573–580. (Article in Japanese)

    PubMed  CAS  Google Scholar 

  36. Eisenbrand G, Preussmann R, Schmahl D. Carcinogenicity of N-nitrosoephedrine in rats. Cancer Lett. 1978;5:103–106.

    Article  PubMed  CAS  Google Scholar 

  37. Wogan GN, Paglialunga S, Archer MC, Tannenbaum SR. Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine. Cancer Res. 1975;35:1981–1984.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshimitsu Toyama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toyama, Y., Shimizu, H., Suzuki, Y. et al. Genotoxic effects of N-nitrosoketamine and ketamine as assessed by in vitro micronucleus test in Chinese hamster lung fibroblast cell line. Environ. Health Prev. Med. 11, 120–127 (2006). https://doi.org/10.1265/ehpm.11.120

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1265/ehpm.11.120

Key words

Navigation